Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
2023-11-09 04:23
Swiss Stocks Are Lagging Eurozone Peers By the Most Since 1999
Switzerland’s typically staid stock market is headed for its worst annual showing against euro zone peers since 1999,
2023-11-08 15:22
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:47
Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs
Novo Nordisk A/S sales surged in the third quarter as demand continued unabated for its obesity and diabetes
2023-11-02 16:26
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
2023-11-02 14:49
Novartis Lifts Outlook After Shedding Sandoz Generics
Novartis AG raised its profit forecast for a third time in the drugmaker’s first report after spinning off
2023-10-24 15:58
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:59
China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims
One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after
2023-10-17 14:50
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
2023-10-16 19:20
A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
2023-10-14 07:25
LVMH Sales Growth Slows as Global Luxury Demand Cools
LVMH shares fell after the world’s largest luxury group reported softer sales growth in the third quarter —
2023-10-11 15:58
Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals
Novo Nordisk A/S said a kidney failure study of its diabetes drug Ozempic showed effectiveness surprisingly early, sending
2023-10-11 15:54